Nexalin Technology R&D Spending Growth & History (NXL)
Nexalin Technology's r&d spending was $1.1M for fiscal 2025.
View full Nexalin Technology company overviewNexalin Technology annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $1.1M | −$107,362 | −9.02% |
| 2024 | 2024-12-31 | $1.2M | −$730,927 | −38.03% |
| 2023 | 2023-12-31 | $1.9M | $1.4M | +276.09% |
| 2022 | 2022-12-31 | $511,000 | $372,000 | +267.63% |
| 2021 | 2021-12-31 | $139,000 | — | — |
Nexalin Technology quarterly r&d spending
| Fiscal quarter | Period ended | R&D spending | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $564,480 | $338,706 | +150.02% |
| Q1 2026 | 2026-03-31 | $346,382 | −$59,906 | −14.74% |
| Q4 2025 | 2025-12-31 | $224,940 | −$512,301 | −69.49% |
| Q3 2025 | 2025-09-30 | $226,520 | $47,955 | +26.86% |
| Q2 2025 | 2025-06-30 | $225,774 | $56,364 | +33.27% |
| Q1 2025 | 2025-03-31 | $406,288 | $300,620 | +284.49% |
| Q4 2024 | 2024-12-31 | $737,241 | $665,771 | +931.54% |
| Q3 2024 | 2024-09-30 | $178,565 | −$1.5M | −89.10% |
| Q2 2024 | 2024-06-30 | $169,410 | $23,410 | +16.03% |
| Q1 2024 | 2024-03-31 | $105,668 | $39,835 | +60.51% |
| Q4 2023 | 2023-12-31 | $71,470 | −$284,808 | −79.94% |
| Q3 2023 | 2023-09-30 | $1.6M | $1.5M | +1342.13% |
| Q2 2023 | 2023-06-30 | $146,000 | $116,460 | +394.25% |
| Q1 2023 | 2023-03-31 | $65,833 | $54,268 | +469.24% |
| Q4 2022 | 2022-12-31 | $356,278 | — | — |
| Q3 2022 | 2022-09-30 | $113,617 | $80,143 | +239.42% |
| Q2 2022 | 2022-06-30 | $29,540 | — | — |
| Q1 2022 | 2022-03-31 | $11,565 | — | — |
| Q3 2021 | 2021-09-30 | $33,474 | — | — |
Nexalin Technology r&d spending trends
Between the periods ended 2021-12-31 and 2025-12-31, Nexalin Technology's r&d spending increased from $139,000 to $1.1M, a change of $944,522. The latest reported quarter, Q2 2026, shows $564,480.
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
SEC-reported R&D expense
TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Nexalin Technology source filings ↗